DK1252164T3 - Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre - Google Patents

Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre

Info

Publication number
DK1252164T3
DK1252164T3 DK01905691T DK01905691T DK1252164T3 DK 1252164 T3 DK1252164 T3 DK 1252164T3 DK 01905691 T DK01905691 T DK 01905691T DK 01905691 T DK01905691 T DK 01905691T DK 1252164 T3 DK1252164 T3 DK 1252164T3
Authority
DK
Denmark
Prior art keywords
compound
preparation
formula
pyrrolizin
chlorophenyl
Prior art date
Application number
DK01905691T
Other languages
Danish (da)
English (en)
Inventor
Thomas Kammermeier
Stefan Laufer
Philipp Merckle
Hans-Guenter Striegel
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/001047A external-priority patent/MXPA00001047A/xx
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK1252164T3 publication Critical patent/DK1252164T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01905691T 2000-01-28 2001-01-26 Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre DK1252164T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA/A/2000/001047A MXPA00001047A (en) 2000-01-28 Method for producing 6-(4-chlorophenyl) -2,2-dimethyl-7- phenyl -2,3-dihydro- 1h-pyrrolizine- 5-yl acetic acid
PCT/EP2001/000852 WO2001055149A1 (de) 2000-01-28 2001-01-26 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure

Publications (1)

Publication Number Publication Date
DK1252164T3 true DK1252164T3 (da) 2004-07-05

Family

ID=32589023

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01905691T DK1252164T3 (da) 2000-01-28 2001-01-26 Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre

Country Status (31)

Country Link
US (1) US6417371B1 (sr)
EP (1) EP1252164B1 (sr)
JP (1) JP5143326B2 (sr)
KR (1) KR100749222B1 (sr)
CN (1) CN1160357C (sr)
AT (1) ATE262529T1 (sr)
AU (1) AU779616B2 (sr)
BG (1) BG65567B1 (sr)
BR (1) BR0107898A (sr)
CA (1) CA2397767C (sr)
CU (1) CU23193A3 (sr)
DE (1) DE50101761D1 (sr)
DK (1) DK1252164T3 (sr)
EA (1) EA004938B1 (sr)
EE (1) EE05125B1 (sr)
ES (1) ES2218382T3 (sr)
GE (1) GEP20043408B (sr)
HK (1) HK1047590A1 (sr)
HR (1) HRP20020707B1 (sr)
HU (1) HUP0300604A3 (sr)
IS (1) IS2404B (sr)
NZ (1) NZ520429A (sr)
PL (1) PL208027B1 (sr)
PT (1) PT1252164E (sr)
RS (1) RS50374B (sr)
SK (1) SK286608B6 (sr)
TR (1) TR200400691T4 (sr)
TW (1) TWI289561B (sr)
UA (1) UA72580C2 (sr)
WO (1) WO2001055149A1 (sr)
ZA (1) ZA200206832B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141285A1 (de) * 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) * 2006-03-23 2007-09-27 Unichem Laboratories Limited Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
PL2350082T3 (pl) * 2008-10-31 2015-08-31 C A I R Biosciences Gmbh Sól likofelonu z choliną i trometaminą
US10206904B2 (en) 2015-07-17 2019-02-19 The Board Of Regents Of The University Of Oklahoma Licofelone derivatives and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie

Also Published As

Publication number Publication date
HRP20020707B1 (en) 2006-05-31
US6417371B1 (en) 2002-07-09
CN1160357C (zh) 2004-08-04
NZ520429A (en) 2003-08-29
GEP20043408B (en) 2004-06-10
US20020028953A1 (en) 2002-03-07
EE05125B1 (et) 2009-02-16
BR0107898A (pt) 2002-11-05
HRP20020707A2 (en) 2004-12-31
PL208027B1 (pl) 2011-03-31
BG106951A (en) 2003-07-31
TR200400691T4 (tr) 2004-11-22
AU3371101A (en) 2001-08-07
TWI289561B (en) 2007-11-11
JP5143326B2 (ja) 2013-02-13
YU56502A (sh) 2005-06-10
EE200200417A (et) 2003-12-15
RS50374B (sr) 2009-11-10
SK286608B6 (sk) 2009-02-05
CA2397767C (en) 2008-05-06
EA004938B1 (ru) 2004-10-28
CA2397767A1 (en) 2001-08-02
KR20020075895A (ko) 2002-10-07
CU23193A3 (es) 2007-03-23
WO2001055149A1 (de) 2001-08-02
JP2004517799A (ja) 2004-06-17
ES2218382T3 (es) 2004-11-16
BG65567B1 (bg) 2008-12-30
EP1252164B1 (de) 2004-03-24
IS6475A (is) 2002-07-19
EA200200740A1 (ru) 2002-12-26
ZA200206832B (en) 2003-10-07
UA72580C2 (en) 2005-03-15
PT1252164E (pt) 2004-08-31
EP1252164A1 (de) 2002-10-30
DE50101761D1 (de) 2004-04-29
SK10432002A3 (sk) 2003-02-04
IS2404B (is) 2008-09-15
PL356774A1 (en) 2004-07-12
AU779616B2 (en) 2005-02-03
HUP0300604A2 (hu) 2003-07-28
HK1047590A1 (en) 2003-02-28
HUP0300604A3 (en) 2003-10-28
KR100749222B1 (ko) 2007-08-13
ATE262529T1 (de) 2004-04-15
CN1396922A (zh) 2003-02-12

Similar Documents

Publication Publication Date Title
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
DK1373207T3 (da) Nyt amlodipincamsylat og fremgangsmåde til fremstilling heraf
DK1252164T3 (da) Fremgangsmåde til fremstilling af 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-eddikesyre
RU2019105577A (ru) Способ получения соединения пиразоламида
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
MY128460A (en) Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
ATE329900T1 (de) Verfahren zur herstellung von 2-pyrrolidon
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
AU2018101865A4 (en) Coordination agent trichloromethyl benzyl acetate production plant
DE50106283D1 (de) Herstellung der 2-Oxo-1,3-dibenzyl-cis-4,5-imidazolidindicarbonsäure bzw. ihres Anhydrids
CO5280193A1 (es) Proceso para preparar acido 6-(4-clorofenil)-2,2-dimetil-7- fenil-2,3-dihidro-1h-pirrolizin-5-il acetico
UY26708A1 (es) Proceso para preparar ácido 6 - (4 - clorofenil) - 2, 2 - dimetil - 7 - fenil - 2, 3 - dihidro - 1 h - pirrolizin - 5 - ilacético.
IE20180519U1 (en) Coordination agent trichloromethyl benzyl acetate production plant
DK1073625T3 (da) Tilidinmesylat, fremgangsmåder til dets fremstilling og et farmaceutisk præparat deraf
JP2006045123A (ja) ４−ヒドロキシ−２−メチルチオピリミジンの製造方法
MXPA04003629A (es) Nuevos derivados propionicos beta-fenil-alfa oxisubstituidos: procesos para su preparacion y su uso en la preparacion de compuestos farmaceuticamente importantes.
EG25330A (en) Preparation of lactams.
WO2002030876A3 (en) Cyclic carboxylic acids as integrin antagonists
ATE297376T1 (de) Verfahren zur herstellung von alkyl-n- alkylanthranilate
JP2018002680A (ja) カルボニル化合物の製造方法
DK1296965T3 (da) Fremgangsmåde til fremstilling af 4-brom-anilinderivater
PL42394B1 (sr)
KR970042509A (ko) 2, 6-디클로로-5-플루오로니코틴산의 제조방법